SHYIELD™ efficacy against COVID-19
SHYIELD™, formulated with Accelerated Hydrogen Peroxide®, is approved for use against some of the world’s most dangerous pathogens under Health Canada’s Broad-Spectrum Virucide claim for Emerging Viral Pathogens, including SARS-CoV-2, the virus that causes COVID-19
In cases of emerging viral pathogens like SARS-CoV-2, the virus that causes COVID-19, when there is no test that can be conducted to validate the efficacy of a disinfectant against an emerging viral pathogen, Health Canada utilizes the Broad Spectrum Virucide claim to determine the expected efficacy of a disinfectant against an emerging virus. This guidance, used previously during the 2003 SARS epidemic, mandates that for disinfectant products to be approved they must have proven efficacy against one of the following four non-enveloped viruses; Adenovirus type 5, Bovine Parvovirus, Canine Parvovirus, and Poliovirus type 1.
Knowing that emerging viral pathogens are an increasing public health concern, all SHYIELD™ products are designed to ensure they carry Health Canada’s Broad-Spectrum Virucide claim providing you confidence that you are covered in the event of any emerging viral pathogen outbreak.
The Technology that Powers Shyield™
We welcome you to take a look at the process behind the technology that powers SHYIELD™. As presented by The Wall Street Journal
Virox Technologies Inc. AHP formula is the cutting edge technology behind SHYIELD™. To get us where we are today, AHP has been trusted and accepted in a multitude of industries, just to name a few; hospitals, cruise ships, animal health, and dentistry.
- 2H Media Collaborator